Regulatory Compliance Granulation Technology, Inc. operates a fully cGMP compliant facility and is FDA GDUFA listed, indicating strong adherence to high safety and quality standards. This positions the company as a reliable partner for clients requiring strict regulatory compliance in pharmaceutical manufacturing.

Manufacturing Capabilities With a 35,000 sq. ft. facility registered to handle controlled substances from Class II to V, GTI can support clients with complex formulation needs and high-quality production demands, opening opportunities for partnerships in controlled substance manufacturing.

Market Focus Serving both small enterprises and Fortune 500 companies highlights GTI's versatility and experience in scaling production, making it an attractive manufacturing partner for growing pharmaceutical businesses seeking quality and reliability.

Quality Standards GTI's commitment to meeting US FDA, USP, GMP, and ISO standards underscores its focus on quality assurance, which appeals to clients prioritizing regulatory compliance and product safety.

Growth Potential With recent revenue estimates between 1 to 10 million dollars and ongoing client acquisition, GTI presents an opportunity for sales expansion among mid-sized pharmaceutical companies seeking high-quality manufacturing solutions.